Funding for this research was provided by:
National Institutes of Health (HL061795, HL119145, HG007690)
Article History
Received: 9 March 2020
Accepted: 15 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Joseph Loscalzo is the scientific co-founder of Scipher Medicine, Inc., a start-up company that uses network medicine to identify biomarkers for disease and specific pathway targets for drug development. The other authors declare no competing interests.